``Triple-H'' therapy for cerebral vasospasm following sub arachnoid hemorrhage. Neur- ocrit Care. 2006;4:68-76.Lee KH, Lukovits T, Friedman JA. “Triple- H”therapy for cerebral vasospasm following subarachnoid hemorrhage [J]. Neurocrit Care, 2006,4(1) : 68-76....
Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets. Researchers are aiming to advance TNBC treatment worldwide. In the
Triple H (HHH) therapy is an established treatment for symptomatic vasospasm following subarachnoid hemorrhage (SAH). RLS has not been reported in the scientific literature as a complication of HHH therapy with perfusion computed tomography (CTP) imaging documentation. Case: A 73-year-old woman ...
The combination of induced hypertension, hypervolemia, and hemodilution constitutes triple H therapy is an option for preventing and treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Although strong clinical evidence is lacking, this therapy may be appropriate for selected cases.Ginat,...
Triple H therapyMRIPosterior leukoencephalopathy syndrome is a rare complication of triple H therapy, which is the treatment for symptomatic vasospasm occurring following subarachnoid hemorrhage. This complication must be considered when neurological deterioration of a patient continues or worsens during triple...
Morbidity and mortality rates for vasospasm are high despite improvements in management. Since the middle of the 1970s, much has been written about the treatment of cerebral vasospasm. Hypervolaemia, hypertension, and haemodilution (triple-H) therapy in an intensive-care setting has been shown in...
Triple H therapyNeuromonitoringThe traditional axiom that vasospasm induced reduction of blood flow leads to poor tissue oxygenation and ischaemic cellular injury culminating in delayed neurological deficits has been challenged and the efficacy of triple H therapy in reversal of the above is debated. In...
European Journal of AnaesthesiologyDearden NM (1998) Triple H therapy in the management of cerebral vasospasm. Eur J Anaesthesiol [Suppl 17] 15:76-78Dearden, NM (1998) Triple H therapy in the management of cerebral vasospasm. Eur J Anaesthesiol 15: pp. 70-79...
708 Prophylactic Triple H Therapy after Aneurysmal Subarachnoid Hemorrhage: A Clinical, Prospective, Randomized, Controlled StudyKeywords Cerebral blood flowCerebral vasospasmHyperdynamic therapyInduced hypertensionNeurological outcomeSubarachnoid hemorrhageOBJECTIVE: To investigate the role of prophylactic hyperdynamic...
Journal of Vascular and Interventional NeurologyWalid MS, Sahiner G, Robinson DR, Robinson JS. The rela- tionship between pulmonary dysfunction and age in vasospasm patients receiving triple H therapy. J Vasc Interv Neurol. 2011;4(2):29-33....